Restless legs syndrome study identifies 13 new genetic risk variants

October 13, 2017
Credit: CC0 Public Domain

A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.

As many as one in ten people of European ancestry is affected by restless legs syndrome, in which sufferers feel an overwhelming urge to move, often in conjunction with unpleasant sensations, usually in the legs. Rest and inactivity provoke the symptoms, whereas movement can lead to temporary relief. The condition is chronic and can get progressively worse, with long-lasting effects on patients' mental and physical health. People with restless legs syndrome have substantially impaired sleep, reduced overall quality of life, and increased risk of depression, anxiety disorders, hypertension, and, possibly, cardiovascular disease.

For around one in 50 people, the condition can be severe enough to require chronic medication, which may in turn have potentially serious side effects.

Studies of families and twins have shown that there is a strong genetic component to the disorder and led to the discovery of six genetic variants that increased the risk of developing the condition.

"We have studied the genetics of restless legs syndrome for more than 10 years and the current study is the largest conducted so far," says Dr Barbara Schormair from the Institute of Neurogenomics at the Helmholtz Zentrum München, first author of the study. "We are convinced that the newly discovered risk loci will contribute substantially to our understanding of the causal biology of the disease."

Now, an international team of researchers has compared the genetic data from over 15,000 patients with more than 95,000 controls, and identified a further 13 genetic risk variants. The findings were then replicated in a sample of 31,000 patients and 287,000 controls. The results are published in Lancet Neurology.

"Restless legs syndrome is surprisingly common, but despite this, we know little about what causes it - and hence how to treat it," says Dr Steven Bell from the Department of Public Health and Primary Care at the University of Cambridge, also one of the first authors on the study. "We already know that it has a strong genetic link, and this was something we wanted to explore in more detail."

Several of the genetic variants have previously been linked to the growth and development of nerve cells - a process known as neurogenesis - and to changes in the formation of neuronal circuits. These findings strengthen the case for restless legs being a neurodevelopmental disorder whose origins may go back to development in the womb as well as impaired nerve cell growth in later life.

"The genetic risk variants that we've discovered add more weight to the idea that this condition is related to the development of our nervous system," says Dr Emanuele Di Angelantonio, also from the Department of Public Health and Primary Care. "It also gives us some clues to how we may treat patients affected by the condition."

Prof Juliane Winkelmann, who heads the Institute of Neurogenomics at the Helmholtz Zentrum as well as a outpatient clinic at the Klinikum Rechts der Isar in Munich, adds: "Our genetic findings are an important step towards developing new and improved treatment options for our patients."

One particular biological pathway implicated by the findings is known to be a target for the drug thalidomide. While the drug has a controversial reputation due to its previous use when treating pregnant women that led to serious birth defects in their offspring, it is now used to treat some cancers. The researchers suggest that thalidomide or similar drugs may offer potential for male patients with and female beyond reproductive age, but they stress the necessity of rigorous clinical testing for efficacy and side-effects before any such use.

Explore further: A new gene identified for restless legs syndrome

More information: Schormair, B., Zhao, C., Bell, S. et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurology; 10th October 2017; DOI: 10.1016/S1474-4422(17)30327-7 , http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30327-7/abstract

Related Stories

A new gene identified for restless legs syndrome

July 14, 2011
People suffering from restless legs syndrome (RLS) experience unpleasant sensations in the legs at night for which the only remedy is movement. Now, an international consortium from Europe, Canada and the US has identified ...

Early brain development implicated in Restless Legs Syndrome

March 19, 2014
In a study published online in Genome Research, researchers of the Helmholtz Zentrum München und the Technische Universität München have demonstrated that a common genetic variant associated with Restless Legs Syndrome ...

People with Parkinson's more likely to have leg restlessness than restless leg syndrome

November 9, 2011
People with Parkinson's disease may be more likely to have a movement disorder called leg motor restlessness, but not true restless legs syndrome as previous studies have suggested, according to a study published in the Nov. ...

Insomnia genes found

June 12, 2017
An international team of researchers has found, for the first time, seven risk genes for insomnia. With this finding the researchers have taken an important step towards the unravelling of the biological mechanisms that cause ...

Recommended for you

Activating MSc glutamatergic neurons found to cause mice to eat less

December 13, 2017
(Medical Xpress)—A trio of researchers working at the State University of New York has found that artificially stimulating neurons that exist in the medial septal complex in mouse brains caused test mice to eat less. In ...

Gene mutation causes low sensitivity to pain

December 13, 2017
A UCL-led research team has identified a rare mutation that causes one family to have unusually low sensitivity to pain.

Scientists discover blood sample detection method for multiple sclerosis

December 13, 2017
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team.

LLNL-developed microelectrodes enable automated sorting of neural signals

December 13, 2017
Thin-film microelectrode arrays produced at Lawrence Livermore National Laboratory (LLNL) have enabled development of an automated system to sort brain activity by individual neurons, a technology that could open the door ...

Intermittent fasting found to increase cognitive functions in mice

December 12, 2017
(Medical Xpress)—The Daily Mail spoke with the leader of a team of researchers with the National Institute on Aging in the U.S. and reports that they have found that putting mice on a diet consisting of eating nothing every ...

Discovery deepens understanding of brain's sensory circuitry

December 12, 2017
Because they provide an exemplary physiological model of how the mammalian brain receives sensory information, neural structures called "mouse whisker barrels" have been the subject of study by neuroscientists around the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Aquilan
not rated yet Oct 16, 2017
Antidepressants like SSRIs in combination with NSAIDS like Ibuprofen or Celebrex at low or maintenance doses seem to alleviate most Restless Legs Syndrome. It is not a cure and symptoms slowly return on cessation of of the meds. This info is based on my personal experience as voluntary counselor to persons with emotional and related problems.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.